EP2395984
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND A SGLT2 INHIBITOR,AND USES THEREOF
:
EP einkaleyfi: Þýðing ekki lögð inn:
11.2.2010:
19.10.2016:
10703474.6
:
10.2.2030
:
PHARMACEUTICAL COMPOSITION COMPRISING LINAGLIPTIN AND A SGLT2 INHIBITOR,AND USES THEREOF
11.2.2010
19.10.2016
:
Boehringer Ingelheim International GmbH:
Binger Strasse 173, 55216, Ingelheim, DE
:
EISENREICH, Wolfram:
Ingelheim Am Rhein, DE
:
152306 P:
13.2.2009:
US
:
EP2010051735:
11.2.2010
:
A61P 3/06, A61P 3/08, A61P 3/10, A61K 31/522, A61K 31/7048, A61K 9/20, A61K 9/36